Skip to main content
letter
. 2021 Apr 24;106:106582. doi: 10.1016/j.leukres.2021.106582

Fig. 1.

Fig. 1

Kaplan Meier Survival Curve. (A) Kaplan Meier survival curve evaluating 52 patients with COVID-19. Overall survival was calculated to be 73 %. (B) Kaplan Meier survival curve evaluating patients who did not receive lympho-depleting chemotherapy within 30 days of their diagnosis (in blue), versus patients who did receive lympho-depleting chemotherapy within 30 days of their diagnosis (in red). P-value calculated to be 0.268.